Tharini SathiamoorthySenior Director
Tharini Sathiamoorthy has over 20 years of experience in federal, state, and global health policy, government affairs, and public affairs. Prior to joining Sirona Strategies, Ms. Sathiamoorthy managed global external affairs efforts at US Pharmacopeia, including communications, alliance development, and public affairs strategy on policy issues impacting medicines quality and antimicrobial resistance at the federal and global level. For seven and a half years, Ms. Sathiamoorthy served as Vice President at AdvaMedDx, the trade association representing diagnostics manufacturers, where she supported government affairs advocacy, health policy, and public affairs efforts at the global, federal, and state levels.
Prior to AdvaMedDx, Ms. Sathiamoorthy was Senior Associate in the health policy practice at APCO Worldwide, a leading public affairs firm. While at APCO, Sathiamoorthy’s work included federal policy outreach and analysis and stakeholder and alliance development for a wide range of clients, including pharmaceutical companies, medical device manufacturers, and health insurers. Ms. Sathiamoorthy previously worked at Marwood Group, a health care financial services firm where she worked with the firm’s private equity clients to help analyze and understand the impact of federal and state legislative and regulatory events on their health care investments. Ms. Sathiamoorthy also served as a consultant with the Lewin Group, where she worked with multiple private and public sector clients on projects to implement policies created by regulators and legislators, as well as on projects to improve their business practices. Prior to Lewin, she worked at the American College of Physicians, where she represented internal medicine subspecialties on Capitol Hill and before federal agencies.
Ms. Sathiamoorthy received a Bachelor of Arts in International Relations and Biology from Boston University and a Master of Health Sciences in Health Policy with a Certificate in Health Finance and Management from the Johns Hopkins Bloomberg School of Public Health.